ad

Narayana Hrudayalaya Q2 Results: Margin Recovery in Focus After UK-Led Revenue Jump

23 Sept 20265:23 pm

Narayana Hrudayalaya Q2 Results: Margin Recovery in Focus After UK-Led Revenue Jump
Narayana Hrudayalaya Q1 FY27 revenue Rs 2,683.63 crore (+78% YoY), PAT Rs 207.27 crore (+5.7% YoY). Q2 FY26 base: revenue Rs 1,643.79 crore, PAT Rs 258.50 crore. Q2 FY27 results date not confirmed.

Quick Answer

Narayana Hrudayalaya's Q2 FY27 results date is not yet confirmed. Q1 FY27 (June 2026 quarter) consolidated revenue jumped 78% YoY to Rs 2,683.63 crore on the full-quarter integration of its UK acquisition, though EBITDA margin compressed to 18.82% from 23.93%. The Q2 FY27 print will be compared against a Q2 FY26 base of Rs 1,643.79 crore revenue and Rs 258.50 crore PAT, with margin recovery the key swing factor.

The Narayana Hrudayalaya Q2 results FY27 print is the next earnings event for this multi-continent hospital chain, arriving as the market judges whether the margin compression seen in Q1 FY27 was a one-quarter integration cost or a lasting shift.

Click Here – Get Free Investment Predictions

When Is the Narayana Hrudayalaya Q2 Results FY27 Date?

Not confirmed; Q1 FY27 was reported on August 3, 2026, so a mid-to-late November date follows the pattern for the September 2026 quarter.

Narayana Hrudayalaya Q2 Results Expectations

No verified consensus exists. The Narayana Hrudayalaya Q2 results watchlist centres on whether EBITDA margin recovers from Q1 FY27's compressed 18.82% (down from 23.93% YoY) as UK integration costs normalise, and whether India hospital operations sustain the 17% YoY growth seen in Q1.

Narayana Hrudayalaya Previous Quarter Performance (Q1 FY27)

Revenue Rs 2,683.63 crore (+78.04% YoY), EBITDA Rs 505.18 crore (+40.04% YoY, margin 18.82%), consolidated PAT Rs 207.27 crore (+5.72% YoY). The UK business contributed Rs 825.7 crore; India hospitals grew 17.0% YoY to Rs 1,324.7 crore.

Narayana Hrudayalaya Q2 FY26 Base Quarter

Revenue Rs 1,643.79 crore, PBIT Rs 339.02 crore, consolidated PAT Rs 258.50 crore, EPS Rs 12.72.

Narayana Hrudayalaya Recent Quarterly Trend

Quarter Revenue (Rs Cr) PAT (Rs Cr)
Q2 FY26 (Sep-25) 1,643.79 258.50
Jun-25 1,507.27 197.15
Mar-25 1,475.44 197.29
Q1 FY27 (Jun-26) 2,683.63 207.27

Key Factors That Could Shape Narayana Hrudayalaya Q2 Results FY27

  • UK integration cost trajectory
  • Doctor professional fees
  • India hospital occupancy and ARPOB
  • Cayman business performance
  • Net debt-to-equity, currently 0.42x

Narayana Hrudayalaya Q2 Results FY27: Valuation Going Into the Print

No forward valuation is implied here; readers should check trailing multiples via a verified source before the print.

Download the Univest iOS App or Univest Android App to track Narayana Hrudayalaya live price and quarterly earnings updates.

What Investors Should Watch When Narayana Hrudayalaya Q2 Results Are Announced

  • EBITDA margin recovery toward the 23%+ range seen a year ago
  • UK segment profitability
  • Whether India same-hospital growth sustains 17%+

Conclusion on Narayana Hrudayalaya Q2 Results FY27

The Narayana Hrudayalaya Q2 results FY27 print will be watched for margin normalisation after Q1's UK-integration-driven compression, against a Q2 FY26 base of Rs 258.50 crore PAT.

Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Narayana Hrudayalaya Q2 Results FY27

What is the Narayana Hrudayalaya Q2 results date for FY27?

Ans. Not confirmed; Q1 FY27 was reported August 3, 2026, so a mid-to-late November date follows the historical pattern.

What were Narayana Hrudayalaya's Q1 FY27 results?

Ans. Revenue of Rs 2,683.63 crore (+78% YoY) and PAT of Rs 207.27 crore (+5.7% YoY), with EBITDA margin compressing to 18.82%.

What was the Q2 FY26 base quarter for Narayana Hrudayalaya?

Ans. Revenue Rs 1,643.79 crore and PAT Rs 258.50 crore, the comparison base for Q2 FY27.

Is Narayana Hrudayalaya a buy ahead of Q2 results?

Ans. This article offers no buy, sell or hold recommendation; consult a SEBI-registered advisor.

Check Narayana Hrudayalaya Live Fundamentals on the Univest Screener

{"@context":"https://schema.org","@type":"FAQPage","mainEntity":[{"@type":"Question","name":"What is the Narayana Hrudayalaya Q2 results date for FY27?","acceptedAnswer":{"@type":"Answer","text":"Not confirmed; Q1 FY27 was reported August 3, 2026, so a mid-to-late November date follows the historical pattern."}},{"@type":"Question","name":"What were Narayana Hrudayalaya's Q1 FY27 results?","acceptedAnswer":{"@type":"Answer","text":"Revenue of Rs 2,683.63 crore (+78% YoY) and PAT of Rs 207.27 crore (+5.7% YoY), with EBITDA margin compressing to 18.82%."}},{"@type":"Question","name":"What was the Q2 FY26 base quarter for Narayana Hrudayalaya?","acceptedAnswer":{"@type":"Answer","text":"Revenue Rs 1,643.79 crore and PAT Rs 258.50 crore, the comparison base for Q2 FY27."}},{"@type":"Question","name":"Is Narayana Hrudayalaya a buy ahead of Q2 results?","acceptedAnswer":{"@type":"Answer","text":"This article offers no buy, sell or hold recommendation; consult a SEBI-registered advisor."}}]}

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down